227 related articles for article (PubMed ID: 29637868)
21. Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.
Wilkie MD; Lau AS; Vlatkovic N; Jones TM; Boyd MT
Oral Oncol; 2018 Aug; 83():1-10. PubMed ID: 30098763
[TBL] [Abstract][Full Text] [Related]
22. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
23. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
Vermorken JB
Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535
[TBL] [Abstract][Full Text] [Related]
24. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations.
Wemmert S; Linxweiler M; Lerner C; Bochen F; Kulas P; Linxweiler J; Smola S; Urbschat S; Wagenpfeil S; Schick B
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1129-1141. PubMed ID: 29560516
[TBL] [Abstract][Full Text] [Related]
25. TP53 and head and neck neoplasms.
Blons H; Laurent-Puig P
Hum Mutat; 2003 Mar; 21(3):252-7. PubMed ID: 12619110
[TBL] [Abstract][Full Text] [Related]
26. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Saloura V; Fatima A; Zewde M; Kiyotani K; Brisson R; Park JH; Ikeda Y; Vougiouklakis T; Bao R; Khattri A; Seiwert T; Cipriani N; Lingen M; Vokes E; Nakamura Y
Clin Cancer Res; 2017 Aug; 23(16):4897-4907. PubMed ID: 28442504
[No Abstract] [Full Text] [Related]
28. HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck cancers.
Kanyilmaz G; Ekinci O; Muge A; Celik S; Ozturk F
Asian Pac J Cancer Prev; 2015; 16(1):253-8. PubMed ID: 25640361
[TBL] [Abstract][Full Text] [Related]
29. [Current Standard of Care in Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Prevention, diagnostics, prognostication and therapy].
Pogorzelski M; Grünwald V
Dtsch Med Wochenschr; 2019 Dec; 144(24):1691-1696. PubMed ID: 31791073
[TBL] [Abstract][Full Text] [Related]
30. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in alcohol and tobacco metabolism genes in head and neck cancer in the Basque Country.
Bediaga NG; Marichalar-Mendia X; Rey-Barja N; Setien-Olarra A; Gonzalez-Garcia JA; de Pancorbo MM; Aguirre-Urizar JM; Acha-Sagredo A
J Oral Pathol Med; 2015 Nov; 44(10):769-75. PubMed ID: 25639971
[TBL] [Abstract][Full Text] [Related]
32. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
33. Racial differences in the relationship between tobacco, alcohol, and squamous cell carcinoma of the head and neck.
Stingone JA; Funkhouser WK; Weissler MC; Bell ME; Olshan AF
Cancer Causes Control; 2013 Apr; 24(4):649-64. PubMed ID: 22674225
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
[TBL] [Abstract][Full Text] [Related]
35. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
37. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.
Beck TN; Kaczmar J; Handorf E; Nikonova A; Dubyk C; Peri S; Lango M; Ridge JA; Serebriiskii IG; Burtness B; Golemis EA; Mehra R
Oncotarget; 2015 Aug; 6(22):18863-74. PubMed ID: 26265441
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
39. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
40. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.
Misiukiewicz K; Camille N; Gupta V; Bakst R; Teng M; Miles B; Genden E; Sikora A; Posner M
Clin Adv Hematol Oncol; 2014 Dec; 12(12):812-9. PubMed ID: 25674839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]